Administering zinc supplements to COVID-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time. At the same time, it could help to prevent risk groups, like the elderly, from suffering ...
Mar 4, 2021
0
9
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania found female and male collegiate athletes take approximately the same amount of time to recover from a concussion, with subtle differences ...
Jan 26, 2021
0
2
Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.
Nov 20, 2020
0
1
People change their minds. Some men who had a vasectomy to become infertile might decide for whatever reason that they want to have more children. In those cases, vasectomy reversal can be an option.
Nov 16, 2020
0
1
About 1 in 5 patients who are on the national waiting list for a liver transplant die or become too sick before an organ becomes available. With an ever-growing need for organs, Mayo Clinic is working to increase awareness ...
Nov 12, 2020
0
2
Remdesivir, a therapeutic to treat Covid-19, boosted third-quarter sales for pharmaceutical company Gilead Sciences by nearly $900 million, according to results released Wednesday by the drugmaker.
Oct 29, 2020
0
1
Donald Trump's brief stay in hospital in early October raised awareness—once again—of the variety of treatments being investigated for COVID-19.
Oct 22, 2020
0
4
It is only 120 millionths of a millimeter in size but can bring entire countries to a standstill: the Corona virus. Even if it were to disappear one day, viral infections will still be among the most frequent and difficult-to-treat ...
Oct 8, 2020
0
1
The maker of anti-influenza drug Avigan said Wednesday it will apply for the medication to be approved for treating coronavirus patients after trials showed it can shorten recovery time.
Sep 23, 2020
0
3
(HealthDay)—Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment, remdesivir. The antiviral drug will take the brand name Veklury, the company said.
Aug 12, 2020
0
1
